FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/022158 [Registered on: 26/11/2019] Trial Registered Prospectively
Last Modified On: 25/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the effects of Magnesium sulphate and low dose of Dexmedetomidine on haemodynamic responses to laryngoscopy and intubation 
Scientific Title of Study   Comparison of effects of Magnesium sulphate and low dose of Dexmedetomidine on haemodynamic responses to laryngoscopy and intubation  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mahendra Kumar  
Designation  Director Professor 
Affiliation  UCMS and GTB hospital 
Address  Department of Anaesthesiology, Critical Care and Pain Medicine UCMS and GTB hospital, Dilshad Garden,Delhi.

North East
DELHI
110095
India 
Phone  9868399709  
Fax    
Email  mahendramohit@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mahendra Kumar  
Designation  Director Professor 
Affiliation  UCMS and GTB hospital 
Address  Department of Anaesthesiology, Critical Care and Pain Medicine UCMS and GTB hospital, Dilshad Garden,Delhi.

North East
DELHI
110095
India 
Phone  9868399709  
Fax    
Email  mahendramohit@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Kusum  
Designation  Postgraduate Student 
Affiliation  UCMS and GTB hospital 
Address  Department of Anaesthesiology, Critical Care and Pain Medicine UCMS and GTB hospital, Dilshad Garden, Delhi

North East
DELHI
110095
India 
Phone  9354069382  
Fax    
Email  mamacsinghkusum92@gmail.com  
 
Source of Monetary or Material Support  
UCMS and GTB Hospital 
 
Primary Sponsor  
Name  UCMS and GTB hospital 
Address  Dilshad Garden, Delhi-110095 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NA   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Kusum  UCMS and GTB Hospital  Department of Anaesthesia and Critical Care and Pain Medicine/ OT block/4th,5th,6th,7th floor
North East
DELHI 
9354069382

mamacsinghkusum92@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-HR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 4||Measurement and Monitoring,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dexmedetomidine  0.25microgm/kg dexmedetomidine diluted to 100 ml of 0.9% Normal saline will be given Over a period of 10min before induction of anaesthesia 
Comparator Agent  Magnesium sulphate  Magnesium will be given in dose of 50mg/kg diluted to 100 ml of 0.9% Normal saline will be given over a period 10 min before induction of anaesthesia. 
Intervention  Study drug will be administered before induction of anaesthesia  study drug will be diluted to 100 ml on 0.9% normal saline and will be administered intravenously Over a period of 10 min before induction of anaesthesia 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient undergoing elective surgery under
general anaesthesia and requiring
laryngoscopy and endotracheal intubation
Patient belonging to ASA grade I and II
Patient with Mallampati grade I and II
Patient of either gender
Patient of age group 18-60 yrs
 
 
ExclusionCriteria 
Details  Patient not willing to participate in the study
Patient with the history of difficult intubation
Patient with anticipated difficult airway
Patient having BMI>30kg/m2
Patient having history of cardiovascular, cerebral, renal, hepatic, bronchial, endocrine disease or psychiatric disorder
Patient on anti-hypertensive, hypnotic or narcotic drugs
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Difference in SBP following laryngoscopy and intubation in the two groups  Preoperative (base line values) i.e. before infusion of study drug
During medication at 5min, 10min
Pre-induction of anaesthesia
Just before laryngoscopy and intubation
Post intubation at 1 min, 3min, 5min, 7min and 10min
Then every 5 min till the end of surgery 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the heart rate between two groups following laryngoscopy and intubation
To compare Diastolic and Mean blood pressure between two groups
To compare post-operative pain by Numerical Rating score in two groups
To compare post-operative sedation score in two groups
 
Preoperative (base line values) i.e. before infusion of study drug
During medication at 5min, 10min
Pre-induction of anaesthesia
Just before laryngoscopy and intubation
Post intubation at 1 min, 3min, 5min, 7min and 10min
Then every 5 min till the end of surgery
 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/11/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet published. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

this study is purposed to find a suitable drug ( with minimum adverse effects) that can minimise the stress resposes like rise in blood pressure and heart rate during laryngoscopy and intubation in patients planned for surgical intervention under general anaesthesia.

laryngoscopy and intubation can be fatal in patients with cardiovascular and cerebral diseases therefore this study will be focused first on ASA grade I and II patients so that it can further be studied on critically ill patients. It can be helpful in decreasing the mortality associated with the simple procedures like laryngoscopy and intubation.


 
Close